FDA label
What is fingolimod used for?
The FDA-approved uses of fingolimod, quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “Fingolimod capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients 10 years of age and older.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted fingolimod?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Fingolimod, capsule
Indications and Usage, quoted from the label by Camber Pharmaceuticals, Inc. (ANDA207933). Cross-references to other label sections are left out.
Fingolimod capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients 10 years of age and older.
Source: DailyMed label, set id c3199508-3d6a-4e44-96f0-bbde9969edcb, version 5, effective December 18, 2025. NDC 31722-889, one of 20 listings for this product.
Questions
What is fingolimod used for?
The FDA label says: “Fingolimod capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients 10 years of age and older.”
What drug class is fingolimod?
FDA lists fingolimod in the Sphingosine 1-phosphate Receptor Modulator established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.